Biocomposites gains MDR certification for STIMULAN® Rapid Cure and STIMULAN® Kit
STIMULAN® certified to be mixed with a combination of Gram-positive and Gram-negative antibiotics
STIMULAN® certified to resolve infection and reduce the need for secondary surgery
STIMULAN® is the only calcium matrix antibiotic carrier certified for use in bone and surrounding soft tissue
Keele, UK, 5 February 2026 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that its STIMULAN® products have gained European Union Medical Device Regulation (MDR) certification for mixing with the following antibiotics: vancomycin, gentamicin and tobramycin, and the combination of vancomycin with either tobramycin or gentamicin, to assist in the treatment of infection in bone and surrounding soft tissue.
